GlassScriptPhysician profile
Craig D Berteau
NPI 1518130392
$4,280.81
in general payments reported to CMS, 2019-2025
43 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,389 · 2020: $867 · 2021: $306 · 2022: $655 · 2023: $1,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $453.53 | 2019-2023 | Nuplazid |
| Novo Nordisk INC | $323.97 | 2019-2023 | Ozempic, Rybelsus |
| Amgen INC. | $314.10 | 2019-2023 | Otezla, Repatha |
| Abbvie INC. | $281.52 | 2021-2023 | Qulipta, Vraylar |
| Sunovion Pharmaceuticals INC. | $266.64 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $243.53 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $229.52 | 2019-2023 | |
| Supernus Pharmaceuticals, INC. | $223.64 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $200.50 | 2019-2023 | |
| Pfizer INC. | $174.88 | 2023 | |
| Lilly USA, LLC | $119.01 | 2022-2023 | Reyvow, Emgality |
| Allergan, INC. | $117.66 | 2020 | |
| Emd Serono, INC. | $109.93 | 2019-2021 | |
| Sk Life Science, INC. | $99.13 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $98.52 | 2019-2023 | Austedo Xr |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Berteau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.